February 21, 2026

Video: Novel Vasodilator Targets Distal Outflow

At AGS 2026, Barbara Wirostko, MD, FARVO, reviewed top-line data on QLS-111, including additive IOP lowering on latanoprost.

By Barbara M. Wirostko, MD, FARVO

February 21, 2026

Could Blood Flow Reveal Glaucoma Earlier?

A University of Maryland study finds that retinal blood-flow autoregulation may signal early glaucoma before structural damage or vision loss is detectable.

By Jim Gallagher, senior managing editor

February 21, 2026

Navigating Drug Costs in Glaucoma Care

At AGS 2026, Lorraine M. Provencher, MD, outlined practical strategies for using patient assistance programs to reduce medication costs.

By Jim Gallagher, senior managing editor

February 20, 2026

Integrating AI into the Glaucoma Clinic

Newer artificial intelligence tools are designed to automate routine administrative tasks and improve practice efficiency.

By Jim Gallagher, senior managing editor

February 20, 2026

The Future of Glaucoma Care: Protecting the Optic Nerve

In the 2026 AGS Lecture, Louis R. Pasquale, MD, FARVO, discussed how genetics, metabolism, and understanding the impact of myopia on the lamina support system may redefine optic nerve protection.

By Jim Gallagher, senior managing editor

February 20, 2026

Video: Predicting Glaucoma Progression with AI

Cecilia S. Lee, MD, MS, explores how deep learning models could enable earlier intervention and better outcomes.

By Cecilia S. Lee, MD, MS

February 20, 2026

New Possibilities for Minimally Invasive Bleb Surgery

At AGS 2026, Ian F. Pitha, MD, PhD, discussed the current role of MIBS and reviewed investigational devices under development.

By Jim Gallagher, senior managing editor

February 20, 2026

Laser-Titratable Shunt Achieves IOP Reduction at 12 Months

Data presented at AGS 2026 suggest the Calibreye system may offer pressure and medication reduction comparable to existing drainage implants.

By Jim Gallagher, senior managing editor

February 20, 2026

Video: Early iDose TREX Data Show Double-Digit IOP Reduction

Steven R. Sarkisian Jr., MD, reviews early results with the extended-release travoprost implant.

By Steven R. Sarkisian, Jr., MD

February 20, 2026

The Evolving MIGS Pipeline

At AGS 2026, Rachel Simpson, MD, highlighted the latest investigational technologies in minimally invasive glaucoma surgery.

By Jim Gallagher, senior managing editor

February 20, 2026

A Surgical Safety Net for Glaucoma Patients

The AGS Cares program matches patients in need with volunteer surgeons across the United States.

By Jim Gallagher, senior managing editor

February 20, 2026

Diurnal IOP Fluctuation Drops After SLT, Study Finds

A small prospective study using home tonometry showed sustained reductions in intraocular pressure variability through 18 months.

By Jim Gallagher, senior managing editor

February 20, 2026

Which Patients Benefit Most From Repeat SLT?

A retrospective observational study of more than 279,000 eyes may help guide patient selection for repeat SLT.

By Wendy Liu, MD, PHD,